Duo Oncology Selected for Prestigious NCI SBIR Investor Initiatives Program https://lnkd.in/eiaCaJu2
Duo Oncology
制药业
Pittsburgh，Pennsylvania 383 位关注者
Nanomedicines as the foundation of cancer medicine. Platform chemistry designed for patients.
关于我们
Duo Oncology, founded by oncologists, is developing tumor-penetrating nanomedicines to upgraded the foundations of cancer medicine. Duo’s patented platform prodrug chemistry releases creates nanomedicines that penetrate established tumors to reduce toxicity and improve patient outcomes.
- 网站
-
https://www.duooncology.com/
Duo Oncology的外部链接
- 所属行业
- 制药业
- 规模
- 2-10 人
- 总部
- Pittsburgh，Pennsylvania
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Oncology和Pharmaceutical development
地点
-
主要
获取路线
2730 Sidney St
Suite 300
US，Pennsylvania，Pittsburgh，15203
Duo Oncology员工
动态
-
The Galien Foundation, dedicated to innovation to improve the human condition, selects Duo Oncology as Nominee for 2024 Best Startup. (Read more at https://lnkd.in/evTa3x-W)
-
-
Duo Oncology receives additional NIH support to expand its pipeline!
Duo Oncology Selected for NIH I-Corps Accelerator — Duo Oncology
duooncology.com